These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30017858)

  • 1. Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex.
    Kitanaka N; Kitanaka J; Hall FS; Kandori T; Murakami A; Muratani K; Nakano T; Uhl GR; Takemura M
    Pharmacol Biochem Behav; 2018 Sep; 172():9-16. PubMed ID: 30017858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration.
    Meyer AC; Horton DB; Neugebauer NM; Wooters TE; Nickell JR; Dwoskin LP; Bardo MT
    Neuropharmacology; 2011 Sep; 61(4):849-56. PubMed ID: 21669212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
    Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice.
    Kitanaka N; Hall FS; Kobori S; Kushihara S; Oyama H; Sasaoka Y; Takechi M; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
    Pharmacol Biochem Behav; 2021 Oct; 209():173257. PubMed ID: 34418452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
    Podurgiel SJ; Yohn SE; Dortche K; Correa M; Salamone JD
    Behav Brain Res; 2016 Feb; 298(Pt B):188-91. PubMed ID: 26590367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor.
    Kitanaka N; Kitanaka J; Takemura M
    Neurochem Res; 2006 Jun; 31(6):829-37. PubMed ID: 16794857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
    Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
    Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.
    Raffo A; Hancock K; Polito T; Xie Y; Andan G; Witkowski P; Hardy M; Barba P; Ferrara C; Maffei A; Freeby M; Goland R; Leibel RL; Sweet IR; Harris PE
    J Endocrinol; 2008 Jul; 198(1):41-9. PubMed ID: 18577569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
    Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
    Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.
    López-Cruz L; San Miguel N; Carratalá-Ros C; Monferrer L; Salamone JD; Correa M
    Neuropharmacology; 2018 Aug; 138():349-359. PubMed ID: 29408363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
    Cleren C; Naudin B; Costentin J
    Brain Res; 2003 Nov; 989(2):187-95. PubMed ID: 14556940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
    Ugolev Y; Segal T; Yaffe D; Gros Y; Schuldiner S
    J Biol Chem; 2013 Nov; 288(45):32160-32171. PubMed ID: 24062308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine.
    Horton DB; Nickell JR; Zheng G; Crooks PA; Dwoskin LP
    J Neurochem; 2013 Oct; 127(2):177-86. PubMed ID: 23875622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tetrabenazine on the striatal uptake of exogenous L-DOPA in vivo: a PET study in young and aged rhesus monkeys.
    DeJesus OT; Shelton SE; Roberts AD; Nickles RJ; Holden JE
    Synapse; 2002 Jun; 44(4):246-51. PubMed ID: 11984859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
    Kitanaka N; Kitanaka J; Takemura M
    Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.
    Pettibone DJ; Totaro JA; Pflueger AB
    Eur J Pharmacol; 1984 Jul; 102(3-4):425-30. PubMed ID: 6489435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabenazine Facilitates Exocytosis by Enhancing Calcium-Induced Calcium Release through Ryanodine Receptors.
    de Pascual R; Álvarez-Ortego N; de Los Ríos C; Jacob-Mazariego G; García AG
    J Pharmacol Exp Ther; 2019 Oct; 371(1):219-230. PubMed ID: 31209099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adrenal medulla graft on recovery of GABAergic and dopaminergic neuron deficits in mice: behavioural, pharmacological and immunohistochemical study.
    Jousselin-Hosaja M; Tobin C; Venault P; Joubert C; Chapouthier G
    Behav Brain Res; 2003 Mar; 140(1-2):185-93. PubMed ID: 12644291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.